Alerts will be sent to your verified email
Verify Email
SAIPARENT
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sai Parenteral’s Limited is a Hyderabad-based pharmaceutical company engaged in the development, manufacturing, and distribution of parenteral formulations. Established in 2001, it operates WHO-GMP certified facilities and offers injectables and other dosage forms, serving domestic and global markets.
Sai Parenteral's major competitors are Sai Life Sciences, Innova Captab, Senores Pharmaceutic, Gland Pharma.
Market Cap of Sai Parenteral's is ₹0 Crs.
While the median market cap of its peers are ₹12,980 Crs.
Sai Parenteral's seems to be less financially stable compared to its competitors.
Altman Z score of Sai Parenteral's is 0 and is ranked 5 out of its 5 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
